|
Volumn 34, Issue 5, 2006, Pages 287-297
|
Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin
|
Author keywords
Cancer chemotherapeutics; Cell cycle; Cell proliferation; Cyclin dependent kinases; G0 G1 arrest; pRb phosphorylation
|
Indexed keywords
CA 161;
CA 198;
CA 199;
CA 204;
CA 205;
CA 206;
CA 207;
CA 208;
CA 209;
CA 210;
CA 211;
CA 212;
CA 213;
CA 214;
CA 215;
CA 235;
CA 236;
CYCLIN D1;
CYCLIN DEPENDENT KINASE 4;
CYCLIN DEPENDENT KINASE INHIBITOR;
DOUBLE STRANDED DNA;
FASCAPLYSIN;
FASCAPLYSIN DERIVATIVE;
MIMOSINE;
RETINOBLASTOMA PROTEIN;
ROSCOVITINE;
TRYPTAMINE DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER GROWTH;
CANCER INHIBITION;
CELL CYCLE G0 PHASE;
CELL CYCLE G1 PHASE;
CELL CYCLE S PHASE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SPECIFICITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CYCLIN-DEPENDENT KINASE 4;
DNA;
DNA TOPOISOMERASES, TYPE I;
DNA TOPOISOMERASES, TYPE I, EUKARYOTIC;
DNA, SUPERHELICAL;
ENZYME INHIBITORS;
ETHIDIUM;
FLOW CYTOMETRY;
HUMANS;
INDOLES;
NUCLEIC ACID CONFORMATION;
PHOSPHORYLATION;
RETINOBLASTOMA PROTEIN;
|
EID: 33748579945
PISSN: 00452068
EISSN: 10902120
Source Type: Journal
DOI: 10.1016/j.bioorg.2006.06.004 Document Type: Article |
Times cited : (24)
|
References (26)
|